Enter your login e-mail to the account
Search
Search parameters
Search results
- Preoperative preparation of patients undergoing cardiac surgery Part II: Possible influencing of gastrointestinal, neurological and infectious complications
MUDr. Ingrid Porubčinová, PhD., MUDr. Adrián Kolesár, MUDr. František Sabol, PhD.
(6/2012, Review articles ) - Probiotics and their role in prevention and treatment of the H. pylori infection
MUDr. Peter Minárik, MUDr. Dušan Ogurčák, MUDr. Tatjana Hanesová
(12/2009, Review articles ) - Prostate cancer
doc. MUDr. Jozef Marenčák, PhD.
(3/2010, Review articles ) - Onychomycosis – current problem
MUDr. Monika Heizerová, PhD.
(1/2015, Interdisciplinary consilium ) - THE MOST FREQUENT THYROPATHIS IN GENERAL PRACTITIONER´S OFFICE
doc. MUDr. Ján Podoba, CSc.
(5/2005, Topic ) - ARE THE PROBLEMS OF THE TREATMENT OF PEPTIC ULCER DISEASE 23 YEARS AFTER DISCOVERING HELICOBACTER PYLORI SOLVED?
MUDr. Rudolf Hrčka, CSc.
(10/2006, Main topic ) - New treatment options in chronic hepatitis C
Doc. MUDr. Pavol Kristian, PhD., Klinika infektológie a cestovnej medicíny, LF UPJŠ a UNLP, Košice, Doc. MUDr. Mária Belovičová, PhD.
(1/2017, Review articles ) - May probiotics influnce negative outcomes of antibiotic therapy to normal flora?
doc. MUDr. Pavol Jarčuška, CSc.
(2/2007, clearly )
- Differential diagnosis of lymphadenopathy and lymphocytosis, indolent lymphomas
MUDr. Miloš Nosáľ, PhD.
(6/2014, Oncohematology Review ) - Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová, MUDr. Juraj Chudej, PhD.
(6/2014, Oncohematology Review ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Gastric cancer – the view of the gastroenterologist
MUDr. Boris Pekárek, PhD., MUDr. Ľuboš Žitňan, MUDr. Michal Makovník, MUDr. Juraj Májek, PhD.
(3/2011, Review articles ) - Marginal zone lymphoma
MUDr. Juraj Ďuraš , MUDr. Michal Kaščák, prof. MUDr. Roman Hájek, CSc.
(5/2017, Spectrum ) - Immunotherapy in prostate cancer
MUDr. Katarína Rejleková, PhD.
(5/2020, Review articles ) - Kritériá minimálnej reziduálnej choroby pri chronickej lymfocytovej leukémii
MUDr. Juliana Holasová, MUDr. Alexander Wild, RNDr. Soňa Ölvecká, Mgr. Mariana Jacková
(2/2018, Review articles ) - Exosomes – new topic in diagnostics of cancer
RNDr. Ján Sedlák, DrSc., Mgr. Martina Zdurienčíková, RNDr. Paulína Gronesová, PhD., RNDr. Dana Cholujová, PhD., RNDr. Ľuba Hunáková, CSc.
(5/2015, Review articles ) - CHRONIC LYMPHOCYTIC LEUKEMIA – STAGING AND TREATMENT (PART 2)
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová
(6/2008, Review articles ) - Initial treatment of chronic lymphocytic leukaemia
MUDr. Emília Flochová, PhD.
(5/2014, Oncohematology Review )
- Current treatment of external genital warts
MUDr. Katarína Poláková, PhD.
(1/2011, Review articles ) - Onychomycosis – current problem
MUDr. Monika Heizerová, PhD.
(2-3/2013, Review articles ) - Treatment of the nail unit melanoma
MUDr. Martina Vidová Uğurbaş PhD., MPH
(1/2024, Review articles )
- MAY PROBIOTICS INFLUNCE NEGATIVE OUTCOMES OF ANTIBIOTIC THERAPY TO NORMAL FLORA?
doc. MUDr. Pavol Jarčuška, CSc., PharmDr. Lívia Magulová, PhD., MUDr. Pavol Kristian, PhD., h. doc. MUDr. Rudolf Novotný, PhD.
(2/2007, clearly )
- A role of N-acetylcysteine at present practice
doc. RNDr. Eva Račanská, CSc.
(3-4/2015, Information ) - Peptic ulcer disease
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., Mgr. Hedviga Gejdošová
(1/2015, Current pharmacotherapy )
- Hemophilia A and risk of inhibitor development – what changed the SIPPET study?
Prof. MUDr. Ján Staško, PhD., MUDr. Juraj Sokol, PhD., MUDr. Lucia Stančiaková, PhD., MUDr. Tomáš Šimurda, MUDr. Pavol Hollý, PhD, prof. MUDr. Peter Kubisz, DrSc.
(3-4/2017, Main topic )
- Economic aspects of the treatment skin and soft tissue infections with anti-staphylococcal phage lyzate
prof. MUDr. Pavol Jarčuška, PhD.
(1/2015, Original articles )